Invasive Ductal Breast Carcinoma Not Yet Recruiting Phase 1 Trials for Doxorubicin (DB00997)

Also known as: Invasive Ductal Breast Cancer / Carcinoma, Ductal, Breast / Infiltrating ductular carcinoma / Breast ductal cancer invasive / Breast ductal cancer infiltrating / Infiltrating ductal breast cancer

DBCOND0047004 (Invasive Ductal Breast Carcinoma)Not Yet Recruiting1 IdentifierTitlePurposeDrugs
NCT03749850Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast CancerTreatment